Overall survival by chemo‐/radiotherapy ‐ Chemoradiotherapy · resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
Perioperative chemotherapy probably leads to lower overall survival by chemo‐/radiotherapy ‐ Chemoradiotherapy compared with primary surgery (moderate certainty).
1 finding from 1 review
Intervention not reported
Perioperative mortality · people with pancreatic surgery
It is very uncertain whether the intervention changes perioperative mortality (very low certainty).
1 finding from 1 review
Intervention not reported
Treatment withdrawal · people with pancreatic surgery
It is very uncertain whether the intervention changes treatment withdrawal (very low certainty).
1 finding from 1 review
Intervention not reported
Re‐operation · people with pancreatic surgery
It is very uncertain whether the intervention changes re‐operation (very low certainty).
1 finding from 1 review
Intervention not reported
Anastomotic leak · people with pancreatic surgery
The intervention showed no clear difference in anastomotic leak; GRADE not reported.
1 finding from 1 review
Intervention not reported
Pancreatic fistula (clinically significant) · people with pancreatic surgery
It is very uncertain whether the intervention changes pancreatic fistula (clinically significant) (very low certainty).
1 finding from 1 review
Intervention not reported
Infected abdominal collections · people with pancreatic surgery
The intervention showed no clear difference in infected abdominal collections; GRADE not reported.
1 finding from 1 review
Intervention not reported
Shock · people with pancreatic surgery
The intervention showed no clear difference in shock; GRADE not reported.
1 finding from 1 review
Overall survival (OS) · patients with resectable gastric cancer
Post‐surgical chemotherapy leads to lower overall Survival (OS) compared with surgery alone (high certainty).
1 finding from 1 review
Disease-free survival · patients with resectable gastric cancer
Post‐surgical chemotherapy leads to lower disease Free Survival compared with surgery alone (high certainty).
1 finding from 1 review
Incidence of postoperativeseromaRR · people with breast and axillary surgery
Fibrin glue instillation under skin flaps showed no clear difference in incidence of postoperativeseromaRR compared with no‐fibrin (low certainty).
1 finding from 1 review
Mean volume of seromaSMD · people with breast and axillary surgery
1 finding from 1 review
Total volume of drained seromaSMD · people with breast and axillary surgery
1 finding from 1 review
Number of days for persistent drainageSMD · people with breast and axillary surgery
1 finding from 1 review
Surgical site infection · people with breast and axillary surgery
Fibrin glue instillation under skin flaps showed no clear difference in surgical site infectionRR compared with no‐fibrin (low certainty).
1 finding from 1 review
PostoperativecomplicationsRR · people with breast and axillary surgery
Fibrin glue instillation under skin flaps showed no clear difference in postoperativecomplicationsRR compared with no‐fibrin (low certainty).
1 finding from 1 review
Length of hospital stay (theoretical) · people with breast and axillary surgery
1 finding from 1 review
Overall survival · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon + chemotherapy may leads to higher overall survival compared with chemotherapy alone (low certainty).
1 finding from 1 review
Nausea and vomiting · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon showed no clear difference in adverse event (nausea/ vomiting) compared with observation alone (low certainty).
1 finding from 1 review
Progression‐free survival · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon + chemotherapy may leads to higher progression‐free survival compared with chemotherapy alone (low certainty).
1 finding from 1 review